A citation-based method for searching scientific literature

T R Yeager, A A Neumann, A Englezou, L I Huschtscha, J R Noble, R R Reddel. Cancer Res 1999
Times Cited: 498



Robert Lu, Julienne J O'Rourke, Alexander P Sobinoff, Joshua A M Allen, Christopher B Nelson, Christopher G Tomlinson, Michael Lee, Roger R Reddel, Andrew J Deans, Hilda A Pickett. Nat Commun 2019
Times Cited: 49




List of shared articles



Times cited

Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma.
Simone Minasi, Caterina Baldi, Francesca Gianno, Manila Antonelli, Anna Maria Buccoliero, Torsten Pietsch, Maura Massimino, Francesca Romana Buttarelli. Childs Nerv Syst 2021
2

Alternative lengthening of telomeres is a self-perpetuating process in ALT-associated PML bodies.
Jia-Min Zhang, Marie-Michelle Genois, Jian Ouyang, Li Lan, Lee Zou. Mol Cell 2021
5

NHP2 downregulation counteracts hTR-mediated activation of the DNA damage response at ALT telomeres.
Maya Raghunandan, Dan Geelen, Eva Majerova, Anabelle Decottignies. EMBO J 2021
3

ALT Positivity in Human Cancers: Prevalence and Clinical Insights.
Danny MacKenzie, Andrea K Watters, Julie T To, Melody W Young, Jonathan Muratori, Marni H Wilkoff, Rita G Abraham, Maria M Plummer, Dong Zhang. Cancers (Basel) 2021
2

RPA shields inherited DNA lesions for post-mitotic DNA synthesis.
Aleksandra Lezaja, Andreas Panagopoulos, Yanlin Wen, Edison Carvalho, Ralph Imhof, Matthias Altmeyer. Nat Commun 2021
0

Chromatin mobility and relocation in DNA repair.
Noa Lamm, Samuel Rogers, Anthony J Cesare. Trends Cell Biol 2021
0

DNA replication: the recombination connection.
Esther A Epum, James E Haber. Trends Cell Biol 2021
1

ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156.
Balakrishna Koneru, Ahsan Farooqi, Thinh H Nguyen, Wan Hsi Chen, Ashly Hindle, Cody Eslinger, Monish Ram Makena, Trevor A Burrow, Joanne Wilson, Aaron Smith,[...]. Sci Transl Med 2021
0

Clinical Relevance of Alternative Lengthening of Telomeres in Cancer.
Guilherme G da Silva, Karollyne S Morais, Daniel S Arcanjo, Diêgo M de Oliveira. Curr Top Med Chem 2020
0

ALT: A Multi-Faceted Phenomenon.
Aurore Sommer, Nicola J Royle. Genes (Basel) 2020
5

Alternative Lengthening of Telomeres in Pediatric Cancer: Mechanisms to Therapies.
Thomas Kent, Deanne Gracias, Samuel Shepherd, David Clynes. Front Oncol 2020
7

Alternative Lengthening of Telomeres: Building Bridges To Connect Chromosome Ends.
Song My Hoang, Roderick J O'Sullivan. Trends Cancer 2020
15


Telomere length heterogeneity in ALT cells is maintained by PML-dependent localization of the BTR complex to telomeres.
Taylor K Loe, Julia Su Zhou Li, Yuxiang Zhang, Benura Azeroglu, Michael Nicholas Boddy, Eros Lazzerini Denchi. Genes Dev 2020
22

RAD54 promotes alternative lengthening of telomeres by mediating branch migration.
Emily Mason-Osann, Katherine Terranova, Nicholas Lupo, Ying Jie Lock, Lisa M Carson, Rachel Litman Flynn. EMBO Rep 2020
4


ALTernative Functions for Human FANCM at Telomeres.
Beatriz Domingues-Silva, Bruno Silva, Claus M Azzalin. Front Mol Biosci 2019
6

Telomere Maintenance in Pediatric Cancer.
Sandra Ackermann, Matthias Fischer. Int J Mol Sci 2019
1